Interview Dawn Barry the new President and Co-founder of LunaDNA
Q: In a sentence, what is Luna DNA going to do?...
Q: In a sentence, what is Luna DNA going to do?...
Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives? ...
Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?...
Q: What are the benefits of the Precision BioSciences’ ARCUS genome editing platform and what makes it unique?...
Q: Olink has been rapidly growing its’ library of human protein biomarker assays. What are the popular clinical applications for your biomarker panels?...
Q: How will genomics transform healthcare and how will it impact medicine? Beyond genetics and genomics what other data is relevant and why?...
Q: What are some of the key unique ideas behind the Biomedical Intelligence Cloud? What contextual knowledge do you bring in?...
Q: What are the challenges that the field of genomic research will face in the next five years?...
Q: What are the challenges facing clinical interpretation of NGS data today?...
The cloud will be the big data platform with the associated machine-learning and artificial intelligence services that will truly enable healthcare to be data-driven...